AbCheck discovers and optimizes human therapeutic antibodies with one of the industry's most versatile technology platforms. Tailored to your specific needs and Target Product Profile, we design an approach leveraging both cutting edge (e.g. microfluidics, rabbit mass humanization) and classical (e.g. phage/yeast display libraries) technologies to provide high quality leads.